AR039402A1 - Derivados de acil-3-carboxifenilurea, procedimientos y su uso como antidiabetico - Google Patents

Derivados de acil-3-carboxifenilurea, procedimientos y su uso como antidiabetico

Info

Publication number
AR039402A1
AR039402A1 ARP030101246A ARP030101246A AR039402A1 AR 039402 A1 AR039402 A1 AR 039402A1 AR P030101246 A ARP030101246 A AR P030101246A AR P030101246 A ARP030101246 A AR P030101246A AR 039402 A1 AR039402 A1 AR 039402A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
alkynyl
alkenyl
phenyl
Prior art date
Application number
ARP030101246A
Other languages
English (en)
Spanish (es)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of AR039402A1 publication Critical patent/AR039402A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP030101246A 2002-04-11 2003-04-09 Derivados de acil-3-carboxifenilurea, procedimientos y su uso como antidiabetico AR039402A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10215908A DE10215908B4 (de) 2002-04-11 2002-04-11 Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
AR039402A1 true AR039402A1 (es) 2005-02-16

Family

ID=28684936

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101246A AR039402A1 (es) 2002-04-11 2003-04-09 Derivados de acil-3-carboxifenilurea, procedimientos y su uso como antidiabetico

Country Status (23)

Country Link
EP (1) EP1497263B1 (https=)
JP (1) JP4328212B2 (https=)
KR (1) KR20040097332A (https=)
CN (1) CN1263734C (https=)
AR (1) AR039402A1 (https=)
AT (1) ATE404532T1 (https=)
AU (1) AU2003232192A1 (https=)
BR (1) BR0309130A (https=)
CA (1) CA2481819A1 (https=)
DE (2) DE10215908B4 (https=)
HR (1) HRP20040931A2 (https=)
HU (1) HUP0500203A2 (https=)
IL (1) IL164248A0 (https=)
MA (1) MA27195A1 (https=)
MX (1) MXPA04009239A (https=)
NO (1) NO20044881L (https=)
NZ (1) NZ535833A (https=)
PL (1) PL371317A1 (https=)
RS (1) RS88704A (https=)
RU (1) RU2004133046A (https=)
TW (1) TW200401765A (https=)
WO (1) WO2003084923A1 (https=)
ZA (1) ZA200407361B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215907A1 (de) * 2002-04-11 2003-11-06 Aventis Pharma Gmbh Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
DE10306502B4 (de) * 2003-02-17 2005-03-17 Aventis Pharma Deutschland Gmbh Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7241787B2 (en) 2004-01-25 2007-07-10 Sanofi-Aventis Deutschland Gmbh Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA867420B (en) * 1985-09-30 1987-05-27 Union Carbide Corp Pesticidal 1-(4-aryloxyphenyl)-3-benzoyl urea compounds and process for preparation
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
FI974437A7 (fi) * 1995-06-06 1997-12-05 Pfizer Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogee nifosforylaasi-inhibiittoreina
WO2000056707A1 (en) * 1999-03-24 2000-09-28 Sepracor, Inc. Diaryl thioethers, compositions and uses thereof
US20010053791A1 (en) * 2000-03-16 2001-12-20 Babcock Walter C. Glycogen phosphorylase inhibitor
TR200401029T4 (tr) * 2000-06-09 2004-06-21 Aventis Pharma Deutschland Gmbh Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
PE20021091A1 (es) * 2001-05-25 2003-02-04 Aventis Pharma Gmbh Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion

Also Published As

Publication number Publication date
HK1075650A1 (en) 2005-12-23
CN1263734C (zh) 2006-07-12
PL371317A1 (en) 2005-06-13
IL164248A0 (en) 2005-12-18
EP1497263B1 (de) 2008-08-13
TW200401765A (en) 2004-02-01
NZ535833A (en) 2006-03-31
DE10215908B4 (de) 2005-08-18
WO2003084923A1 (de) 2003-10-16
HRP20040931A2 (en) 2005-02-28
ATE404532T1 (de) 2008-08-15
BR0309130A (pt) 2005-02-01
JP2005522481A (ja) 2005-07-28
CN1646486A (zh) 2005-07-27
MXPA04009239A (es) 2005-01-25
AU2003232192A1 (en) 2003-10-20
ZA200407361B (en) 2006-02-22
MA27195A1 (fr) 2005-01-03
DE50310320D1 (de) 2008-09-25
RS88704A (sr) 2007-02-05
DE10215908A1 (de) 2003-11-06
CA2481819A1 (en) 2003-10-16
NO20044881L (no) 2005-01-07
KR20040097332A (ko) 2004-11-17
RU2004133046A (ru) 2005-04-20
EP1497263A1 (de) 2005-01-19
JP4328212B2 (ja) 2009-09-09
HUP0500203A2 (hu) 2005-06-28

Similar Documents

Publication Publication Date Title
AR039403A1 (es) Derivados de acil-4-carboxifenilurea y su uso como antidiabetico
AR047516A1 (es) Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico, procesos para su preparacion y su uso como medicamentos
AR040477A1 (es) Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos
AR039402A1 (es) Derivados de acil-3-carboxifenilurea, procedimientos y su uso como antidiabetico
AR044719A1 (es) Derivados de fenilo y piridinilo, su uso, un proceso para prepararlos, y medicamentos que los contienen
AR060990A1 (es) Acidos carboxilicos sustituidos con fenilaminobenzoxazol y composiciones farmaceuticas que los contienen, utilizadas para el tratamiento de la diabetes
AR063786A1 (es) Derivados de 1,4 -benzotiepina-1,1 dioxido sustituidos con radicales bencilo, productos farmaceuticos que comprenden estos compuestos y su uso
AR040474A1 (es) Derivados de tiofenolglicosido, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos
TR200402069T4 (tr) Difenilüre türevleri ve bunların alfa 2/5-HT2c antagonisti olarak kullanılması
AR042437A1 (es) Derivados de fluoroglicosidos heterociclicos, medicamentos que los contienen y usos
AR028914A1 (es) 2-guanidino-4-aril-quinazolinas como inhibidores de nhe-3
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
AR039689A1 (es) Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso
AR079541A1 (es) Compuestos sustituidos de n-(1h-indazol-4-il) imidazo (1,2-a) piridin-3-carboxamida como inhibidores de cfms
AR039868A1 (es) Inhibidores selectivos de la enzima kalikreina plasmatica
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR044495A1 (es) Amidas sustituidas de acido carboxilico, su preparacion y su uso como medicamentos
CO5261565A1 (es) Inhibidores de n-(5-(((5-alquil-2-oxazolil)metil)tio)-2-tiazolil)-carboxamida de cinasas dependientes de ciclina
AR040338A1 (es) Uso de derivados de tio-oxindol en el tratamiento de trastornos de la piel
AR018915A1 (es) Inhibidores de proteasas diacilhidrazinicos, composicion farmaceutica que la comprenden, usos de los mismos para la manufactura de un medicamento, unprocedimiento de fabricacion de dichos compuestos
AR027744A1 (es) Compuestos de eter difenilico utiles en terapia
AR042733A1 (es) Derivados de piridinas utilizados como inhibidores del mecanismo de intercambio na+/ca2+
AR029343A1 (es) USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN
AR050576A1 (es) Oxadiazolonas con actividad agonista de ppar-delta. composiciones farmaceuticas.

Legal Events

Date Code Title Description
FB Suspension of granting procedure